{"disease":{"id":"dermatologic-complication","name":"dermatologic complication"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05966779","title":"Physical Therapy in Lipedema Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":293,"lead_sponsor_name":"University of Alcala","has_results":false},{"nct_id":"NCT04258904","title":"Prevention of Skin Problems With Diabetes Devices in Pediatric Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":236,"lead_sponsor_name":"Copenhagen University Hospital at Herlev","has_results":false},{"nct_id":"NCT01416688","title":"S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride","phase":"","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":false},{"nct_id":"NCT01393821","title":"Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab","phase":"NA","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04327752","title":"Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT01867294","title":"Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}